Press Releases

Showing 141-175 of 261


2011

December

December 19

Abbott and University of Illinois Establish Center for Nutrition, Learning and Memory

December 15

Abbott to Present at J.P. Morgan Healthcare Conference

December 12

Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Next-Generation Antioxidant Inflammation Modulators

December 9

Abbott Declares 352nd Consecutive Quarterly Dividend

December 8

Abbott Initiates Clinical Trial to Evaluate the Absorb™ Bioresorbable Vascular Scaffold Compared to a Metallic Drug Eluting Stent
 

November

November 30

Abbott Receives FDA Clearance for New Test to Detect Vitamin D Levels

November 28

Abbott Expands Agreement with GSK to Include Development of a Companion Diagnostic Test for an Additional Investigational Cancer Immunotherapy Antigen

November 21

Abbott Introduces the First FDA-Approved Supplemental Blood Test for Chagas Disease

November 15

Abbott Statement on the Results of the AIM-HIGH Study Presented at AHA 2011

November 14

New Data Reinforce Clinical Performance of Abbott's ABSORB Bioresorbable Vascular Scaffold

November 9

Abbott Receives CE Mark for New Hepatitis Test

November 8

Abbott Reports Five-Year Data for HUMIRA® (Adalimumab) in Ankylosing Spondylitis

November 7

Abbott Presents HUMIRA® (Adalimumab) Phase 3 Study Results for Patients with Active Non-Radiographic Axial Spondyloarthritis

November 6

Abbott Announces New Long-Term Data Evaluating Use of HUMIRA® (Adalimumab) for Patients with Long-Standing Moderate to Severe Rheumatoid Arthritis and for Patients with Early Moderate to Severe RA

November 4

Abbott Announces Winners of "CFChef Challenge" Recipe Contest as Part of Online Nutrition Resource for People Affected by Cystic Fibrosis

November 4

Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility

November 3

PATH, Abbott and the Abbott Fund Form Innovative Partnership to Prevent Malnutrition

November 3

Abbott to Present New Data for Key Vascular Products at TCT 2011

November 2

Abbott to Present Broad Spectrum of Compelling Data for HUMIRA® (Adalimumab) at American College of Rheumatology Annual Scientific Meeting

November 2

Abbott to Present at 2011 Credit Suisse Annual Health Care Conference

November 2

Experts Report that Abbott’s New PLEX-ID Assay Offers Important Testing Capabilities for Biothreat Defense

November 1

Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent
 

October

October 27

Abbott's Lupron Depot-PED (leuprolide acetate for depot suspension) 1-Month Formulation Now Includes 18-Year Long-Term Data in Label

October 27

Abbott Launches Glucerna® Hunger Smart™ Nutrition Products for People with Diabetes

October 25

Abbott Awards CFCareForward Scholarships to Two Students Living with Cystic Fibrosis Pursuing Undergraduate and Graduate Degrees

October 24

Abbott Honored With Asian CSR Award for Leadership in Science Education

October 24

Abbott's Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA

October 22

Biogen Idec and Abbott Present Positive Data for Daclizumab HYP from Select Phase 2b Trial at ECTRIMS/ACTRIMS

October 19

Abbott Reports Strong Ongoing Third Quarter Results; Confirms Double-Digit Ongoing Earnings Growth Outlook for 2011

October 19

Abbott to Separate into Two Leading Companies in Diversified Medical Products and Research-Based Pharmaceuticals

October 17

Abbott's ABSORB™ Bioresorbable Vascular Scaffold Honored with Wall Street Journal Technology Innovation Award

October 5

Abbott Hosts Conference Call for Third-Quarter Earnings

October 4

Abbott Enrolls First U.S. Patient in Global EXCEL Trial Comparing XIENCE to Coronary Artery Bypass Surgery
 

September

September 29

Abbott Announces Availability of Two New CE-Marked Molecular Assays for its m2000 System to Detect Infections Spread in Healthcare Settings

September 20

Abbott Named Top Dealmaker for Fourth Consecutive Year by The Deal